Europe lags China and the US in clinical research, trials and translation to the market

First part of the long-awaited Biotech Act aims to cut clinical trial timelines, slash costs and boost incentives

Rare disease community celebrates measures to boost innovation, but industry warns agreement will not be sufficient to attract investment to Europe

Expansion plans aim to increase national breeding capacity to reduce primate imports, especially from China

The deal aims to strike a balance between incentivising the development of innovative medicines and ensuring patient access